Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of Aα proline-18 by leucine. - Yoshida, N; Okuma, M; Jirata, H; Matsuda, M; Yamazumi, K; Asakura, S (Blood, 1991)